Ratings Surperformance

Trader
Investor
Global
-
Quality
ESG MSCI
-

Ratings ESG MSCI

Ratings Abbott India Limited: Strengths and Weaknesses

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation
Highlights: Abbott India Limited
  • The earnings growth currently anticipated by analysts for the coming years is particularly strong.
  • Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
Weaknesses: Abbott India Limited
  • With an expected P/E ratio at 35.98 and 32.25 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • The company appears highly valued given the size of its balance sheet.
  • The valuation of the company is particularly high given the cash flows generated by its activity.

Rating Financials

Abbott India Limited SectorIndia

Fundamentals

Growth

Revenue growth

EPS growth

FCF growth

Profitability

EBITDA Margin

EBIT Margin

Net Margin

Capital Efficiency

ROA

ROCE

ROE

Financial Health

Gearing

Leverage

Capital Intensity

Balance sheet growth

Long Term balance sheet growth

Long term revenue growth

Long term EPS growth

More ratings

Rating Valuation

Abbott India Limited SectorIndia

Global Valuation

Enterprise value

EV/Revenue

EV/EBITDA

EV/FCF

Equity Valuation

P/E

PBR

Dividend Yield

EV/EBIT

CAPEX/Revenue

More ratings

Rating Consensus

Abbott India Limited SectorIndia

Consensus

-

Analysts' buy/sell recommendations

-

Analysts' recommendations evolution (1 year)

-

Analysts' recommendations evolution (4 months)

-

Analysts' target price

-

Analysts' target price evolution (1 year)

-

Analysts' target price evolution (4 months)

-

Analysts' recommendations evolution (7 days)

-

Target Price evolution (7 days)

-
More ratings

Rating Business Predictability

Abbott India Limited SectorIndia

Visibility

-

Analysts' coverage

Financial estimates divergence

-

Analysts' recommendations divergence

-

Analysts' Target price divergence

-

Surprise rates

Rating Revisions

Abbott India Limited SectorIndia

Financial revisions

Revenue revisions (1 year)

Revenue revisions (4 months)

EPS revisions (1 year)

EPS revisions (4 months)

EPS revisions (7 days)

Revenue revisions (7 days)

More ratings

Capi.($) Investor ESG MSCI Fundamentals Financial revisions Global Valuation Visibility Consensus
616.05Cr - - -
93TCr
A
59TCr
BBB
41TCr
AA
38TCr
AA
32TCr
A
31TCr
AAA
30TCr
A
22TCr
A
20TCr
A
Average 36.58TCr
AA
Weighted average by Cap.
AA
  1. Stock Market
  2. Equities
  3. ABBOTINDIA Stock
  4. Ratings Abbott India Limited